296. 胆道閉鎖症 Biliary atresia Clinical trials / Disease details
臨床試験数 : 63 / 薬物数 : 65 - (DrugBank : 37) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 63
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02298218 (ClinicalTrials.gov) | September 2009 | 19/11/2014 | Clinical Study About the Role of COX-2 Inhibitor in Liver Cirrhosis With Biliary Atresia | Biliary Atresia, Kasai Portoenterostomy Status | Drug: Meloxicam | Yonsei University | NULL | Completed | 2 Years | 17 Years | Both | 50 | Phase 4 | NULL |